Protein Tyrosine Phosphatase, Non-Receptor Type 13
"Protein Tyrosine Phosphatase, Non-Receptor Type 13" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of non-receptor protein tyrosine phosphatases that is characterized by the presence of an amino-terminal FERM domain, an intervening region containing five different PDZ domains, and a carboxyl-terminal phosphatase domain. In addition to playing a role as a regulator of the FAS RECEPTOR activity this subtype interacts via its PDZ and FERM domains with a variety of INTRACELLULAR SIGNALING PROTEINS and CYTOSKELETAL PROTEINS.
MeSH Number(s)
D08.811.277.352.650.775.300.860
D12.644.360.585.860
D12.776.476.564.860
Concept/Terms
Protein Tyrosine Phosphatase, Non-Receptor Type 13- Protein Tyrosine Phosphatase, Non-Receptor Type 13
- Protein Tyrosine Phosphatase, Non Receptor Type 13
- Protein-Tyrosine Phosphatase BAS
- Phosphatase BAS, Protein-Tyrosine
- Protein Tyrosine Phosphatase BAS
- Protein-Tyrosine Phosphatase 1E
- Protein Tyrosine Phosphatase 1E
- Protein Tyrosine Phosphatase BL
- Protein Tyrosine Phosphatase, Basophil Like
Below are MeSH descriptors whose meaning is more general than "Protein Tyrosine Phosphatase, Non-Receptor Type 13".
Below are MeSH descriptors whose meaning is more specific than "Protein Tyrosine Phosphatase, Non-Receptor Type 13".
This graph shows the total number of publications written about "Protein Tyrosine Phosphatase, Non-Receptor Type 13" by people in Harvard Catalyst Profiles by year, and whether "Protein Tyrosine Phosphatase, Non-Receptor Type 13" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
Below are the most recent publications written about "Protein Tyrosine Phosphatase, Non-Receptor Type 13" by people in Profiles.
-
Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut. 2019 03; 68(3):389-399.
-
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer. PLoS One. 2018; 13(2):e0192157.
-
Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance. Tumour Biol. 2016 Jul; 37(7):9691-8.
-
Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology. 2015 Dec 10; 12:102.
-
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers. PLoS One. 2015; 10(8):e0134965.
-
Understanding the effect of alternative splicing in the folding and function of the second PDZ from protein tyrosine phosphatase-BL. Sci Rep. 2015 Mar 19; 5:9299.
-
The mechanism of binding of the second PDZ domain from the Protein Tyrosine Phosphatase-BL to the Adenomatous Polyposis Coli tumor suppressor. Protein Eng Des Sel. 2014 Aug; 27(8):249-53.
-
Autophagy chews Fap to promote apoptosis. Nat Cell Biol. 2014 Jan; 16(1):23-5.
-
ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers. PLoS One. 2012; 7(1):e30447.
-
Agitation and high ionic strength induce amyloidogenesis of a folded PDZ domain in native conditions. Biophys J. 2009 Mar 18; 96(6):2289-98.